GGrantIndex
← Leaderboards

University Of Manitoba

Winnipeg, MB

Compare ↔
$39,223,560
Total funding
19
Grants

Funding over time

peak $5.3M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

CDC$26,227,287 · 2
NIH$12,996,273 · 17

By mechanism

U2G$18,582,325 · 1
R01$12,333,946 · 13
U62$7,644,962 · 1
R21$212,000 · 1
R34$207,050 · 1
U10$163,177 · 1

Investigators at University Of Manitoba

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Meghan Brianne Azad$2,767,5192 gr

Emerging Leaders

6–10 yrs in

1Frederick Adam Zeiler$80,1001 gr

All-Time

Most funded here, all years

1Meghan Brianne Azad$2,767,5192 gr2Francis A Plummer$2,721,0122 gr3Ma Luo$1,721,3122 gr4Harvey M Chochinov$1,576,1201 gr5Frank A Plummer$1,396,2341 gr6Larry M Jordan$850,0001 gr7Kenneth G Standing$795,4161 gr8Meir H Kryger$756,5722 gr

Largest grants

PS10-10133: INCREAS. ACC. TO QUAL. COMP. HIV PREVENTION SERVICES FOR MOST-AT-R$3,173,109
U2G · FY2015 · PS
HIV TREATMENT FOR RESEARCH SUBJECTS OR BY RESEARCHERS IN KENYA$2,945,000
U62 · FY2009 · PS
PS10-10133: INCREAS. ACC. TO QUAL. COMP. HIV PREVENTION SERVICES FOR MOST-AT-R$2,860,831
U2G · FY2016 · PS
INCREASING ACCESS TO QUALITY COMPREHENSTIVE HIV PREVENTION SERVICES FOR MOST-AT-R$2,698,585
U2G · FY2012 · PS
INCREASING ACCESS TO QUALITY COMPREHENSTIVE HIV PREVENTION SERVICES FOR MOST-AT-R$2,563,330
U2G · FY2012 · PS
HIV TREATMENT FOR RESEARCH SUBJECTS OR BY RESEARCHERS IN KENYA$2,054,493
U62 · FY2008 · PS
INCREASING ACCESS TO QUALITY COMPREHENSTIVE HIV PREVENTION SERVICES FOR MOST-AT-R$1,759,700
U2G · FY2011 · PS
PS10-10133: INCREAS. ACC. TO QUAL. COMP. HIV PREVENTION SERVICES FOR MOST-AT-R$1,613,090
U2G · FY2014 · PS
HIV TREATMENT FOR RESEARCH SUBJECTS OR BY RESEARCHERS IN KENYA$1,603,762
U62 · FY2010 · PS
PS10-10133: INCREAS. ACC. TO QUAL. COMP. HIV PREVENTION SERVICES FOR MOST-AT-R$1,262,200
U2G · FY2013 · PS
PS10-10133: INCREAS. ACC. TO QUAL. COMP. HIV PREVENTION SERVICES FOR MOST-AT-R$1,089,310
U2G · FY2014 · PS
INCREASING ACCESS TO QUALITY COMPREHENSTIVE HIV PREVENTION SERVICES FOR MOST-AT-R$770,000
U2G · FY2011 · PS
A Novel HIV-1 Vaccine Targeting the 12 protease Cleavage Sites$758,828
R01 · FY2016 · AI
A Novel HIV-1 Vaccine Targeting the 12 protease Cleavage Sites$712,570
R01 · FY2017 · AI
The Multi-Omic Milk (MuMi) Study: Leveraging the IMiC Platform and the CHILD Cohort to study human milk as a biological system and understand its composition, determinants and impacts on child health$692,078
R01 · FY2023 · HD
A Novel HIV-1 Vaccine Targeting the 12 protease Cleavage Sites$679,120
R01 · FY2015 · AI
A Novel HIV-1 Vaccine Targeting the 12 protease Cleavage Sites$641,949
R01 · FY2014 · AI
INCREASING ACCESS TO QUALITY COMPREHENSTIVE HIV PREVENTION SERVICES FOR MOST-AT-R$592,170
U2G · FY2013 · PS
The Multi-Omic Milk (MuMi) Study: Leveraging the IMiC Platform and the CHILD Cohort to study human milk as a biological system and understand its composition, determinants and impacts on child health$545,085
R01 · FY2025 · HD
The Multi-Omic Milk (MuMi) Study: Leveraging the IMiC Platform and the CHILD Cohort to study human milk as a biological system and understand its composition, determinants and impacts on child health$502,998
R01 · FY2024 · HD